Evidence map›Paper›PMID 28722160›Full record

ArticleAlcoholism, clinical and experimental research2017

Placental Proteomics Reveal Insights into Fetal Alcohol Spectrum Disorders.

Katie L Davis-Anderson, Sebastian Berger, Emilie R Lunde-Young, Vishal D Naik, Heewon Seo, Greg A Johnson, Hanno Steen, Jayanth Ramadoss

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Katie L Davis-AndersonDepartment of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas.
Sebastian BergerDepartments of Pathology, Harvard Medical School and Boston Children's Hospital, Boston, Massachusetts.
Emilie R Lunde-YoungDepartment of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas.
Vishal D NaikDepartment of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas.
Heewon SeoDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas.
Greg A JohnsonDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas.
Hanno SteenDepartments of Pathology, Harvard Medical School and Boston Children's Hospital, Boston, Massachusetts.
Jayanth RamadossDepartment of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas.ORCID http://orcid.org/0000-0002-9778-5224
Texas College · USBoston Children's Hospital · USTexas A&M University · US

Funding

A Novel Mechanistic Framework for FASD Etiology.R01AA023520 · NIAAA · WAYNE STATE UNIVERSITY · PI RAMADOSS, JAYANTH · 2015 to 2024
$3.5M
Maternal Uterine Vascular Origins of Fetal Alcohol Spectrum DisordersR00AA019446 · NIAAA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI RAMADOSS, JAYANTH · 2011 to 2013
$730k
A Novel Platform for Maternal Alcohol Consumption ScreeningR21AA023035 · NIAAA · TEXAS A&M AGRILIFE RESEARCH · PI RAMADOSS, JAYANTH · 2015 to 2016
$421k
Maternal Uterine Vascular Origins of Fetal Alcohol Spectrum DisordersK99AA019446 · NIAAA · UNIVERSITY OF WISCONSIN-MADISON · PI RAMADOSS, JAYANTH · 2010 to 2011
$267k
NIAAA NIH HHS K99 AA019446NIAAA NIH HHS R00 AA019446NIAAA NIH HHS R01 AA023520NIAAA NIH HHS R21 AA023035
6 · The paper itself

Abstract

backgroundFetal alcohol spectrum disorders (FASD) describe many of the well-known neurodevelopmental deficits afflicting children exposed to alcohol in utero. The effects of alcohol on the maternal-fetal interface, especially the placenta, have been less explored. We herein hypothesized that chronic binge alcohol exposure during pregnancy significantly alters the placental protein profile in a rat FASD model.

methodsPregnant rats were orogastrically treated daily with alcohol (4.5 g/kg, gestational day [GD] 5 to 10; 6.0 g/kg, GD 11 to 19) or 50% maltose dextrin (isocalorically matched pair-fed controls). On GD 20, placentae were collected, flash-frozen, and stored until tissues were homogenized. Protein lysates were denatured, reduced, captured on a 10-kDa spin filter, and digested. Peptides were eluted, reconstituted, and analyzed by a Q Exactive™ Hybrid Quadrupole-Orbitrap™ mass spectrometer.

resultsMass spectrometry (MS) analysis identified 2,285 placental proteins based on normalized spectral counts and 2,000 proteins by intensity-based absolute quantification. Forty-five placental proteins were significantly (p < 0.05) altered by gestational alcohol exposure by both quantification approaches. These included proteins directly related to alcohol metabolism; specific isoforms of alcohol dehydrogenase and aldehyde dehydrogenase were up-regulated in the alcohol group. Ingenuity analysis identified ethanol degradation as the most significantly altered canonical pathway in placenta, and fetal/organ development as most altered function, with increased risk for metabolic, neurological, and cardiovascular diseases. Physiological roles of the significantly altered proteins were related to early pregnancy adaptations, implantation, gestational diseases, fetal organ development, neurodevelopment, and immune functions.

conclusionsWe conclude that the placenta is a valuable organ not only to understand FASD etiology but it may also serve as a diagnostic tool to identify novel biomarkers for detecting the outcome of fetal alcohol exposure. Placental MS analysis can offer sophisticated insights into identifying alcohol metabolism-related enzymes and regulators of fetal development.

Indexed as

ProteomicsAnimalsBinge DrinkingCentral Nervous System DepressantsEthanolFemaleFetal Alcohol Spectrum DisordersMass SpectrometryPlacentaPregnancyPregnancy ProteinsRatsRats, Sprague-DawleyCentral Nervous System DepressantsEthanolPregnancy ProteinsAlcoholFetal Alcohol Spectrum DisordersTeratology

Identifiers

PMID28722160
PMCPMC5581221
OpenAlexW2738084828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.